A comparison of population-based cancer incidence rates in Israel and Jordan

L. S. Freedman, M. Barchana, S. Al-Kayed, M. B. Qasem, J. L. Young, B. K. Edwards, L. A.G. Ries, S. Roffers, J. Harford, M. Silbermann

Research output: Contribution to journalArticlepeer-review


Reliable information about comparative cancer incidence in the Middle East has been lacking. The Middle East Cancer Consortium (MECC) has formed a network of population-based registries with standardized basic data. Here the age-adjusted cancer incidences are compared for four populations: Israeli Jews, Israeli non-Jews, Jordanians and the US Surveillance Epidemiology and End Results (SEER) population, for the years 1996-1997 (Israel) and 1996-1998 (other populations). The all-sites rate of cancer is approximately twice as high in Israeli Jews and SEER, compared with Israeli non-Jews and Jordanians. Rates of lung cancer are similar among Israeli Jews and non-Jews and about twice as high as in Jordanians. Childhood leukaemia rates in Jordan are higher than in Israeli Jews, but lower than SEER. Hodgkin lymphoma rates in Israeli non-Jews and Jordanians are similar to SEER, but non-Hodgkin lymphoma rates are lower than SEER. The previous suspicion of higher overall leukaemia and lymphoma rates in Jordan is thus not confirmed.

Original languageEnglish
Pages (from-to)359-365
Number of pages7
JournalEuropean Journal of Cancer Prevention
Issue number5
StatePublished - Oct 2003
Externally publishedYes


  • Israel
  • Jordan
  • Leukaemia
  • Lymphoma
  • Neoplasms
  • Registries

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Oncology
  • Cancer Research
  • Epidemiology


Dive into the research topics of 'A comparison of population-based cancer incidence rates in Israel and Jordan'. Together they form a unique fingerprint.

Cite this